EHC and EUPATI Partner to Advance Patient Education and Engagement in Therapeutic Innovation
The European Haemophilia Consortium (EHC) recently shared an announcement post on X:
”EHC has partnered with The European Patients’ Academy on Therapeutic Innovation to enhance education and research for European Patients. Together, we’ll strengthen the voice of the rare Bleeding Disorders community & improve outcomes across Europe.”
To read more, follow the link.
European Haemophilia Consortium has announced a new partnership with the European Patients’ Academy of Therapeutic Innovation (EUPATI), a nonprofit foundation dedicated to educating patients and the public on the medicine development process.
Representing over 120,000 individuals with rare bleeding disorders, the Consortium brings deep patient insight and multi-stakeholder collaboration to the alliance.
This partnership reflects both organizations’ shared commitment to empowering patients and strengthening the role of informed, engaged communities in shaping the future of healthcare.
Learn about the latest major collaborations in the field of Rare Diseases with Hemostasis Today.
-
Jul 11, 2026, 23:36Emmanuel J Favaloro: A Fresh Perspective on the Manual Tilt Tube Method for PT and INR Determination
-
Jul 11, 2026, 21:44Timos Papagatsias: From Promising Concepts to Clinical Differentiation at ISTH 2026
-
Jul 11, 2026, 21:43Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
-
Jul 11, 2026, 21:41Bianca Constantin: Don’t Miss the ISTH Early Career Committee Activities
-
Jul 11, 2026, 21:38Fateme Babaha: Don’t Miss Your Favorite ISTH 2026 Sessions
-
Jul 11, 2026, 21:11Farjah Algahtani: Learning, Sharing, and Collaborating at ISTH 2026
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey
-
Jul 11, 2026, 19:19Rens De Groot: New Proteomic Evidence Reveals Early Hemolysis During ADAMTS13 Relapse in Immune TTP